Ribonuclease A — LLMpedia

Ribonuclease A
No machine-readable author provided. Vossman assumed (based on copyright claims) · CC BY-SA 2.5 · source
Name	Ribonuclease A
Organism	Bos taurus
Length	124

Contents

Ribonuclease A Ribonuclease A is a well-studied pancreatic enzyme originally isolated from Bos taurus that served as a model in structural biology, enzymology, and protein folding research. It has informed landmark studies associated with investigators from institutions such as Harvard University, Massachusetts Institute of Technology, and Max Planck Society, and appears in foundational texts tied to figures like Linus Pauling, Christian B. Anfinsen, and Max Perutz. The enzyme’s importance extends into applied research connected with companies and agencies including GlaxoSmithKline, Genentech, and the National Institutes of Health.

Introduction

Ribonuclease A was first characterized in detail in the early 20th century and became central to experimental programs at laboratories such as Cold Spring Harbor Laboratory, Rockefeller University, and University of Cambridge. Its prominence increased after experiments by Anfinsen linked primary sequence to native fold, influencing awards like the Nobel Prize in Chemistry and shaping programs at organizations including the Royal Society and American Chemical Society. The enzyme is a compact, robust model that influenced methods developed at facilities such as European Molecular Biology Laboratory and instrumentation from Bruker used by groups at Stanford University and California Institute of Technology.

The three-dimensional fold was solved using techniques pioneered at X-ray crystallography laboratories like those of William Lawrence Bragg and further refined by groups associated with Max Perutz and Dorothy Hodgkin. The canonical structure comprises four disulfide bonds, a compact α/β topology, and surface loops studied by labs at University of Oxford, ETH Zurich, and University of Tokyo. Key active-site residues include histidines and lysines whose positions were elucidated through collaborations involving Brookhaven National Laboratory, European Synchrotron Radiation Facility, and researchers at Yale University. Crystallographic models deposited by teams from University of California, San Francisco and Imperial College London informed mutagenesis experiments performed at Scripps Research and Johns Hopkins University.

Mechanistic proposals trace to acid–base catalysis concepts developed by scientists at University of Chicago and Princeton University, with catalytic roles assigned to two histidine residues and a lysine understood through kinetic and structural studies at MIT and Columbia University. Transition-state stabilization models were refined by computational groups at Stanford University and Lawrence Berkeley National Laboratory using methods parallel to those in studies at Los Alamos National Laboratory and IBM Research. Classic experiments from laboratories at Harvard Medical School demonstrated transphosphorylation and hydrolysis steps, while isotope-labeling work from University of Pennsylvania and University of Michigan supported detailed proposals for proton transfer and nucleophile positioning.

In mammalian physiology, the enzyme participates in RNA metabolism pathways investigated in contexts linked to institutions such as Mayo Clinic, Cleveland Clinic, and Karolinska Institute. It contributes to extracellular RNA degradation processes relevant to host defense topics studied by groups at Centers for Disease Control and Prevention, Johns Hopkins Bloomberg School of Public Health, and Imperial College London. Studies involving immunology departments at National Institute of Allergy and Infectious Diseases and clinical centers including Massachusetts General Hospital explored connections between ribonuclease activity and innate immunity, with implications for pathologies investigated at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute.

Kinetic parameters were measured using approaches and instrumentation from vendors such as Agilent Technologies and platforms used by labs at University of California, Berkeley and ETH Zurich. The enzyme shows preference for single-stranded RNA substrates containing pyrimidine nucleotides, conclusions reinforced by teams at University of Toronto and McGill University employing rapid-quench and stopped-flow methods developed at Beckman Coulter. Comparative kinetics with nucleases studied at Karolinska Institute and Weizmann Institute of Science clarified turnover numbers and Michaelis–Menten behavior, while mutagenesis results from Cold Spring Harbor Laboratory and National Institute of Standards and Technology illuminated contributions of individual residues to catalytic efficiency.

Ribonuclease A and engineered variants influenced reagent development used by companies such as Thermo Fisher Scientific and New England Biolabs for RNA removal in molecular biology workflows standardized at laboratories like Geneva University Hospitals and Institut Pasteur. Therapeutic exploration by biotech firms including Amgen and academic spin-outs from University of Cambridge evaluated cytotoxic ribonucleases and conjugates in oncology programs conducted at institutions like Memorial Sloan Kettering Cancer Center and Fred Hutchinson Cancer Center. Diagnostic and single-cell applications developed by startups with ties to Broad Institute and Illumina leveraged RNase-related protocols in pipelines used at Wellcome Sanger Institute and clinical labs affiliated with Karolinska University Hospital.

Phylogenetic analyses by groups at Harvard University, University of Oxford, and Max Planck Institute for Evolutionary Anthropology traced homologs across vertebrates, with gene-family expansions documented in datasets curated by Ensembl and National Center for Biotechnology Information. Homologous ribonucleases in humans, rodents, and ruminants were compared in studies published by investigators at University College London, Seoul National University, and Peking University; these works informed classification schemes used by consortia such as the Human Genome Project and the 1000 Genomes Project. Isoform diversity, regulatory sequences, and expression patterns were analyzed using tools developed at European Bioinformatics Institute and computational resources at High-Performance Computing Center Stuttgart.

Category:Enzymes